All In MedTech

Device Trial Radar · NCT07010705

Digital Measures for Clinical Trial Endpoints in Huntington's Disease

Digital Measures for Clinical Trial Endpoints in Huntington's Disease (MEND-HD)

Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Jun 20, 2025

Primary completion

Aug 31, 2027

Study completion Nov 30, 2027

Sponsor

Lead sponsor
University of RochesterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Food and Drug Administration (FDA)
First posted
Jun 8, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 25 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

MEND-HD is a longitudinal study evaluating the feasibility of passive monitoring of gait and chorea in patients with HD and the meaningfulness of these outcomes for patients with HD and their care partners/support persons. Participants will take part in four virtual visits with study investigators to answer survey questions on movement and cognition, perform in-home movement assessments, and take part in an interview regarding the meaningfulness of gait and chorea in their daily lives. Participant and care partner interviews will be used for symptom mapping and qualitative data analysis to assess the relevance and impact of the targeted symptoms on the participant's daily life. The study may be extended to 3 years to include yearly visits.

Conditions

  • Huntington Disease
  • Healthy

Interventions

  • ActiGraph LEAPDevice

    The ActiGraph LEAP has received 510(k) clearance from the US FDA and offers extensive sensor collections, providing continuous digital measures of activity, sleep, mobility, and additional vital signs, including heart rate and variability, oxygen saturation, and skin temperature, in a single fit-for-purpose device.

  • Axivity AX6Device

    The Axivity AX6 is a data logger capable of recording raw data from a suite of integrated sensors. It features a state of the art 6-Axis movement sensor measuring linear acceleration and angular velocity at high precision. All sensor locations and Orientations are identical to the AX3 for maximum compatibility. All data is stored in its raw, unaltered format on the embedded flash memory.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Inter-Method Reliability of Total Time in Chorea (Trunk-Worn vs. Wrist-Worn Device)Time frame: 1 week
  2. Known Group Validity of Total Time in Chorea (Trunk-Worn Device)Time frame: 1 week
  3. Known Group Validity of Total Time in Chorea (Wrist-Worn Device)Time frame: 2 weeks

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Rochester Medical Center

    Rochester, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.